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The World Health Organization/International Union of Immunological Societies
(WHO/IUIS) Allergen Nomenclature Sub-Committee was established in 1986 by leading
allergists to standardize names given to proteins that cause IgE-mediated reactions
in humans. The Sub-Committee’s objective is to assign unique names to allergens
based on a critical analysis of confidentially submitted biochemical and clinical data
from researchers, often prior to publication to preserve consistency. The Sub-Committee
maintains and revises the database as the understanding of allergens evolves. This
report summarizes recent developments that led to updates in classification of cockroach
group 1 and 5 allergens to animal as well as environmental and occupational allergens.
Interestingly, routes, doses, and frequency of exposure often affects allergenicity as
does the biochemical properties of the proteins and similarity to self and other proteins.
Information required by the Sub-Committee now is more extensive than previously as
technology has improved. Identification of new allergens requires identification of the
amino acid sequence and physical characteristics of the protein as well as demonstration
of IgE binding from subjects verified by described clinical histories, proof of the presence
of the protein in relevant exposure substances, and demonstration of biological activity
(skin prick tests, activation of basophils, or mast cells). Names are assigned based on
taxonomywith the abbreviation of genus and species and assignment of a number, which
reflects the priority of discovery, but more often now, the relationships with homologous
proteins in related species.
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INTRODUCTION
Advances in molecular biology, recombinant protein technology,
methods of genomic, and proteomic analysis, structural
biology, and high throughput screening have led to a greater
understanding of allergenic proteins over the past 30 years.
Identification of new allergens and improved characterization
dictate the need for revision of some allergens and updated
requirements for allergen nomenclature.
In the 1980’s key clinical and experimental allergists led by
D Marsh at Johns Hopkins University, USA, L Goodfriend
(McGill University, Canada), TP King (Rockefeller University,
USA), H Lowenstein (University of Copenhagen (Denmark)
and TAE Platts-Mills (University of Virginia, USA) framed
basic rules for naming allergenic proteins in common allergenic
sources (1). Over 2 years they agreed to a strategy of naming
allergens based on taxonomy with identification using the
first three letters of the genus, the first letter of the species
and a number for order of identification. The first allergens
were mostly inhalant proteins from pollens of weeds, trees
and grasses and a few from animal dander, fungi, and venom
proteins from stinging insects. The committee recognized that
a systemic standardized nomenclature was needed for consistent
identification in scientific publications. The standardized naming
of allergens has become a formalized process where allergen
names are assigned by the WHO/IUIS Allergen Nomenclature
Sub-Committee after a defined submission process that includes
data on IgE binding to identified novel target proteins or
glycoproteins with the most recent major revision occurring in
2018 (2).
Allergen names are assigned with the first 3 or sometimes 4
letters of the genus, one or sometimes two letters for the species
followed by an Arabic numeral, based on order of discovery (2).
However, the same Arabic number is often used for conserved
protein families in related taxa. Often species have evolved
by duplication of genes with mutations including additions
or deletion of nucleotides to produce alternative proteins of
similar function, resulting in the occurrence of isoallergens as
well as isoforms or variants within the individual organism or
in related organisms of the same species. The isoallergens are
designated by the addition of two digits after the decimal in the
number and isoforms or variants by addition of two more digits
(e.g., Amb a 1.0101). Since the evolutionary steps involved in
generating each new isoform or variant is usually not known,
the committee bases designations on the percent identity of
amino acids compared to the first identified sequence. Sequences
within ∼67% identity to the original allergen are designated
as isoallergens and sequences differing by <90% identity are
isoform or variants.
Expression of recombinant proteins for IgE tests and
characterization has led to more accurate identification. Changes
to the nomenclature have attempted to incorporate an increased
understanding of allergens. Higher resolution studies and
isolation techniques of previously defined allergens now shows
some to be composed of multiple subunits from different genes;
Fel d 1, or multimers; collagen, vicilins, and glycinins. This
manuscript focuses on recent challenges and underlying reasons
for name assignment by the WHO/IUIS Nomenclature Sub-
Committee. We refer those working on allergen identification to
Figure 1, from our 2018 publication with references to specific
sections in this paper to explain the ideal process (2). The
science of allergen determination has improved since 1990, for
characterization of allergenic sources, protein sequences, post-
translational modification determination, improved methods for
measuring IgE binding, mediator release and measurements of
specific bioactivity (skin tests and basophil assays). Scientists
striving to characterize allergens should be aware of and using
techniques appropriate to the types of allergens including those
of foods, contact allergens, aeroallergens and venoms or salivary
sources of allergy.
CHALLENGES FOR FUTURE ALLERGEN
NAMES
Repeated Structure of Group 1 Cockroach
Allergens Is Not Reflected in Current
Allergen Nomenclature
Cockroach allergens from group 1 were difficult to name using
the current WHO/IUIS paradigm. Cloning of the DNA encoding
for Bla g 1 allergen revealed the existence of multiple DNA
repeats encoding approximately 100 amino acids each (3). The
molecular structure of Bla g 1 showed that two tandem amino
acid repeats form a spherical fold (4). A recent analysis of the
Blatella germanica genome (5) suggests there are 5 separate gene
products, and each produce 1 to 5, partial or full repeats of the
Bla g 1 structural motif. In total, there may be 9 other Bla g 1-
like allergens, with 60–90% identity to the Bla g 1 structure. Prior
to the genomic data, it was unclear whether the different Bla g 1
polymorphisms derived from a different gene. In addition, there
was not a precedent for an allergen with this kind of structure and
genomic origin.
Besides cockroaches, it is worthwhile to define new rules
for assigning a nomenclature to this type of allergen, given the
possibility that Bla g 1-like homologs exist in other sources, such
as locusts and mealworms, recently included as food sources.
Allergens belong to a selected group of protein families (6, 7),
and it is likely that any Bla g 1-like homologs in these sources
could also be an allergen. Indeed, a homolog of Bla g 1 was noted
in the genome of Locusta migratoria (8). Further examination
reveals that there are two genes with 2 and 3 copies of the
Bla g 1-like structure, respectively. Other coleopteran species
have been proposed as a substitute protein source in place of
mammalianmeat. A search of genomes of related species revealed
that Tribolium castaneum, has one gene with 9 repeats similar to
the Bla g 1- structure. This repeated sequence structure is likely
to occur in other beetles and there are reported occupational
and food allergies reported from a larval beetle (mealworm) of
Tenebrio molitor (9). Homologs of Bla g 1 can be found in
many other insect species as well (10). So far, the protein(s)
responsible for reactions to mealworm are not yet identified
except for tropomyosin with homology to shrimp proteins. The
structural complexity of allergens like Bla g 1 are not reflected
in the current allergen nomenclature. For similar cases, the
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FIGURE 1 | Overall allergen characterization for submission to the WHO/IUIS Allergen Nomenclature Sub-Committee for possible name recognition. Figure with
copyright allowance from Pomés et al. (2). Numbers are inserted beside key blocks, identifying topical areas and challenges related to our evaluations. (1) Nearly
identical repeated sequences confuse characterization of the natural protein. (2) Amino acid identity matches across distant taxonomic relations are unlikely to
represent cross-reactive proteins. (3) Native allergens of co-valently linked independent proteins such as Fel d 1 and Ory 3. (4) Carbohydrate IgE binding epitopes
(CCD, alpha-gal) are not (yet) named in this system. (5) Studies testing cloned, recombinant proteins without native protein bridging can leave doubts. (6) Biological
evidence, either basophil histamine release or activation, or skin prick test with pure protein. (7) Aeroallergen identities in clinical tests are typically not verified in
allergen diagnostic testing due to lack of available components. (8) Occupational and food allergen testing typically involve few study subjects.
Allergen Nomenclature Sub-Committee discussed the possibility
(not yet approved) of using capital letters behind the allergen
name to signify either the different genes from which the allergen
originated, or different duplexes derived from a gene (i.e., Bla g
1.0101A). Knowledge of the origin of unique allergen structures
may help to define a more informative allergen nomenclature for
these unusual allergens.
Group 5 Cockroach Allergens Are
Glutathione S-Transferases (GSTs),
Consideration of the Degree of Amino Acid
Identity
In recent years the WHO/IUIS Sub-Committee has used
similar allergen numbers for homologous proteins across related
taxonomic groups when possible. Glutathione S-transferases
(GST) are common enzymes present in multiple organisms from
different taxonomic groups. One of the main functions of GSTs
is detoxification by catalyzing the addition of a glutathione
(GSH) molecules to other commonly toxic compounds that
are ultimately removed from the cell (11, 12). Nine groups of
allergens are recognized as GSTs and are listed in the WHO/IUIS
Allergen Nomenclature database (www.allergen.org), including
those from cockroaches (Bla g 5 and Per a 5), mites (Der p 8,
Der f 8 and Blo t 8), helminths (Asc s 13, Asc l 13), fungi (Alt a
13), and plants (Bet v 8) (Figure 2A).
In general, homologous allergens from the same species are
included in the same allergen group as isoallergens (e.g., Cyn d
1.0101 and Cyn d 1.0201 in Table S1) if they share a suggested
threshold of 67% amino acid identity (2). At 67% identity, IgE
cross-reactivity is possible. However, naming additional GSTs
from cockroach in group 5, has been challenging due to their low
sequence identities (down to 18% identity). For those identified
as binding IgE, they could be given a different name and number
(Figure 2B). We considered these enzymes belong to different
protein classes (sigma, delta, theta, mu) as functionally related.
The Bla g 5 from German cockroach (Blattella germanica) was
the first cockroach GST to be identified (O18598), and it is a
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FIGURE 2 | Homologous protein GST allergens are currently categorized as isoallergens with a threshold of 67% amino acid identity although they may belong to
different protein classes (sigma, delta, theta, mu). Percent identities are shown. (A) Nine groups of GST allergens from different taxa to understand sequence identities
across sources. (B) Cockroach GSTs within German and American cockroaches with known allergens and genomic sequences with comparison of amino acid
sequence identities.
sigma class GSTs (11). Additional GSTs from German cockroach
have been identified, though these have not been submitted to
the WHO/IUIS committee with proof of IgE binding: another
sigma GST (EF202178), a theta GST (AEV23882) and two delta
GSTs (ABX57814 and AEV23880). Two GSTs from the American
cockroach (Periplaneta americana) were identified as binding
IgE, and they belong to the delta class of GSTs [MG255130 (13)
and AEV23867] and share 99.54% amino acid identity. When
these GSTs were submitted, we decided to include them as Per
a group 5 proteins even though their identity to Bla g 5 was only
19% identity with Bla g 5. They were named Per a 5.0101 and Per
a 5.0102. If other cockroach GSTs are submitted to the database
in the future, they will be assigned as isoallergens if fitting within
the 67% identity range to the respective group 5 allergens.
GSTs from other species are and have been assigned to other
numbers as seen in Figure 2A (Alt a 13, Bet v 8, Asc a 13,
Blo t 8, Der p 8 amd Der f 8. Isoallergens of each of these
will be assigned, based on sequence comparison, to currently
named members of the respective source species. The committee
now prefers to retain primary allergen numbers the same across
related taxonomic groups, but that is not always possible. It is
important to note that while enzyme functions may be retained
with great diversity in amino acid sequences, the ability for IgE to
bind across those species and meet the criteria of allergenicity is
not retained.
Covalently Linked Dimeric Allergens and
Allergen Nomenclature
Mammalian allergens of the secretoglobin family are
heterodimers, encoded by separate genes. Secretoglobins
(SCGB) represent a large protein family found in mammals and
marsupials. Common characteristics are secretion in many body
fluids, small size, alpha-helical, and dimeric structure creating
a hydrophobic binding pocket (14, 15). Major allergens from
cat and rabbit are Fel d 1 and Ory c 3. Both are glycosylated
heterodimers linked by three disulfid bridges (16, 17). Fel d
1 also forms tetramers composed of two heterodimers. Each
protein chain of the heterodimer is encoded by a single gene
and both are needed to compose the natural molecule and may
be needed for achieving full allergenic activity. The current
allergen nomenclature system did not foresee linked heteromeric
allergens and the names allocation for Fel d 1 and Ory c 3
were not consistent. Whereas, Fel d 1 is listed as Fel d 1.0101
for the dimer, composed of a chain 1 and a chain 2, products
of two separate genes (17), Ory c 3 is listed as 2 isoallergens
with Ory c 3.A.0101, chain A (lypophillin CL2) and Ory c
3.B.0101, chain B (lypophillin AL). The nomenclature for Ory c
3 suggests that both isoallergens have to be considered together
as a full allergen (17). The two proteins do not exist naturally
as monomers and allergenicity can not be assessed individually.
The Sub-Committee recently renamed the Fel d 1 proteins as Fel
d 1.A.0101 for chain 1 and Fel d 1.B.0101 for chain 2, consistent
with the rabbit allergen.
Other examples are recently added allergens, barramundi
collagen Lat c 6 and salmon allergen Sal s 6 proteins. Collagen is a
triple-stranded rope-like coiled structure, composed of 3 protein
chains. Each chain has been given an isoallergen name, despite
the fact that they do not exist as monomers. Currently it is only
possible to evaluate separate IgE binding if using recombinant
monomeric proteins and thus it is not possible to assess the
allergenicity of each of the entire native proteins. The committee
may reevaluate this policy in the future.
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Carbohydrates, New Allergen Epitopes Not
Represented in the Allergen Nomenclature
Database
Cross-reactive carbohydrate determinants (CCDs) are
carbohydrate epitopes carrying an α-1,3-fucose and, or β
1,2 xylose on complex carbohydrates of some glycoproteins
are the main targets of IgE recognition. They are present on
many plant and insect proteins and responsible for extensive
IgE cross-reactivity between different allergen sources (18).
However, there is a general consensus that those glycans do not
trigger noticeable clinical symptoms. Two other carbohydrate
groups have been associated with food allergy and anaphylaxis
(19). Galactose-α-1,3-galactose (α-gal), a carbohydrate present
on mammalian proteins, has been reported to trigger delayed
severe allergic reactions to red meat and to induce acute allergic
reactions upon injection of therapeutic antibodies carrying
α-gal (20, 21). Galacto-oligosaccharides (GOS) are heat-stable,
non-digestable carbohydrates present in milk formula and as
supplement in different beverages. Food allergy to GOS are
reported in Singapore, Vietnam and Japan (19). The structure
and characterization of carbohydrates that are the reported
targets of IgE binding have not been demonstrated, although
they have been assumed to be related to the synthesis of GOS
complexes. Recent work failed to identify the structures or
link them to activation of basophils (22). In contrast to α-gal,
the GOS carbohydrates have not been linked to a protein
backbone (19). So far, only allergens representing protein
epitopes have been named by the WHO/IUIS Nomenclature
Sub-Committee. The committee is currently considering
whether there is enough definition of carbohydrate epitopes
to provide unique names and whether names would be
scientifically useful.
Updating Existing Allergen Entries Named
From Partial Allergen Sequences
Some allergens are characterized based on peptide sequences
from native molecules. In some cases, full-lengh sequences were
not available, but are based on peptide matches to genomic
sequences. That was the case for fish allergens, enolase Sal s 2
and aldolase Sal s 3 from salmon (Salmon salar) based on public
genomic sequences (23). For the salmon allergens Sal s 2 and Sal
s 3, complete sequences were attributed without testing of the
allergenic properties of the corresponding proteins. In the future,
we recommend that an alignment of the complete sequences of
natural or recombinant protein be used to determine IgE binding
be compared to the genome sequence, or at the least, a test of the
recombinant protein be comparison to the native counterpart.
Importantly, different isoforms and variants can exist in the same
source and although highly similar, those proteins can differ
in their allergenic potency (24). Verified information will be
added to the existing database entry in order to further improve
its quality.
Numbering of Allergens
The allergen nomenclature system was originally based on the
order of allergen discovery to provide the allergen number, but
the commitee recognized the conservation of sequences and
structures are important. But sometimes, very similar allergens
from related species receive different numbers (e.g., Fel d 2 and
Can f 3) (25). It would be disruptive to change allergen names
after a number of publications have used established allergen
names and only allergen numbers have been revised and changed
in a few cases (26).
OVERVIEW OF OUTDOOR
ENVIRONMENTAL AEROALLERGENS
Most outdoor aeroallergens are derived from grass, weed and tree
pollen or fungal spore sources. Although Blackley discovered that
pollen caused hay fever in the nineteenth century (27), it was
not until allergenic fractions were purified by chromatography
from ryegrass pollen in the 1960s (28) and cloned in 1990s
(29) that the first pollen allergens were characterized. Because
the sources are typically not recognized due to small sizes of
pollen (10–50 microns) and mold spores (2–50 microns), there
is often uncertainty regarding the causal link between exposure
to a given species and allergic reactions. This is specifally difficult
given the cross-reactivities that exists among allergens from
different species.
The IUIS Allergen Nomenclature Subcommittee recognize
43, 55, and 45 allergens for pollen of grasses, trees and weeds,
respectively. Another four pollen allergens of herbaceous plants
included; Lig v 1 of Ligustrum vulgare (Common privet), Syr v 1
and Syr v 3 of Syringa vulgaris (Lilac) and Hum j 1 of Humulus
japonicus (Japanese hop).
Grass pollen allergens belong to 12 different protein families.
The most abundant proteins of mature pollen that elicits a high
frequency of IgE reactivity are the major group 1 beta-expansin
allergens. The purpose of beta-expansins is to degrade cell walls
and allow pollen tube extensionwhich is essential for fertilization.
A number of IgE and T cell epitope regions are found in close
proximity with the enzymatic domain and specifically the HFD
motif of the N terminal domain (30–32). While allergens of
temperate grass pollens were characterized in 1990s, allergens of
subtropical grass pollens continue to emerge. Grass pollen group
1 allergens among the Pooideae temperate grasses share between
84 and 91% amino acid identity, while subtropical grasses of
Panicoideae, Chloridoideae, and Oryzoideae share between 49
and 86% identity (Table S1). Separate gene loci encode multiple
Poaceae group 1 isoforms. The pollen expansin proteins show
significant sequence diversity, but they apparently share similar
functions exemplified by Cyn d 1 and Sor h 1 isoform diversity
(Table S1). While research shows that there is IgE and T cell
cross-reactivity between group 1 and group 5 grass pollen
allergens across broad taxa, their heterogeneity contributes to the
diversity of immune recognition (33, 34). Themost recently listed
(grass pollen allergen is Uro m 1 of the subtropical Panicoideae
grass Urochloa mutica (Para grass). Group 2 and 3 grass pollen
allergens share approximately 30% identity with the carboxyl
domain of the beta-expansin protein family. Consequently, grass
pollen group 2/3 pollen allergens are smaller in size (10–12 kDa),
but their function is unknown. Sor h 2 and Ory s 2 are described
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in subtropical species, but their clinical importance is less well-
demonstrated. Several isoforms and multiple variants exist for
Group 5 allergens (e.g., for Phl p 5) and these share between 53
and 78% identity between six species for which these allergens
have been characterized (Table S2). Group 5 allergens are absent
from subtropical grass pollen.
Weed pollen allergens arise from 16 species including
ragweed (Ambrosia artemisiifolia), mugwort (Artemisia vulgaris),
pellitory (Parietaria judaica), amaranth, thistle (Salsola kali), and
sunflower (Helianthus annuus) and belong to 10 allergen families.
Clinically important allergens of the Asteraceae family include
pectate lyases (Amb a 1 and Art v 6), defensin-like proteins
(Amb a 4 and Art v 1), non-specific lipid transfer proteins
(Art v 3 and Par j 2), whereas allergens of the Amaranthaceae
family include Ole e 1-like proteins and Che a 1, and pectin
methylesterase (Sal k 1).
Trees from multiple orders; Fagales; for example, Birch
(Betula verrucosa), Lamiales; Ash (Fraxinus excelsior) and
Olive (Olea europaea), Proteales; Plane (Plantanus acerifolia)
and Cupressales; Japanese Cedar (Cryptomeria japonica),
encompassing 21 species contribute allergens belonging to
18 protein families. Clinically important allergens include
Pathogenesis Related protein-10 (Bet v 1, Ole e 1-like protein);
Fra e 1, polygalacturonase; Cry j 2 and Pla a 2, and pectate
lyase; Cry j 1. Profilins are ubiquitous and highly conserved in
sequence and structure (e.g., Phl p 12, Amb a 8 and Bet v 2)
and polcalcins (Phl p 7, Amb a 9, and Ole e 8) are pan-allergens
common to grass, weed and tree pollen, though these allergens
are generally less potent than PR-10 proteins.
A variety of fungi produce the 112 listed WHO/IUIS
allergens from as many as 36 protein families. While fungal
hyphae or spores may be used as food or drug sources,
many are common sources of indoor and outdoor allergy and
a small number colonize human tissues including skin and
lungs. Spores of 15 Ascomycota species belonging to diverse
fungal families; Aspergillaceae, Cladosporiaceae, Didymellaceae,
Nectriaceae, and Pleosporaceae produce 72 airborne outdoor
fungal spore allergens. There are 23 allergens listed forAspergillus
fumigatus including the ribotoxin (Asp f 1), peroxisomal protein
(Asp f 3), metalloprotease (Asp f 5), cyclophilin (Asp f 11),
vacuolar serine protease (Asp f 18), and enolase (Asp f 22),
which are all major allergens. Alternaria alternata spores, one of
commonly recognized fungal spores contains 12 listed allergens
including its major allergens (Alt a 1), and, a glutathione S
transferase (Alt a 13).
OVERVIEW OF OCCUPATIONAL
ALLERGENS FROM FOOD SOURCES
Occupational sensitization has been observed for centuries in
historical and medical writings. The first description of baker’s
asthma was probably by Ramazini around 1700; the first report
of allergic responses to fish was in 1937 by De Besche relating
to a fisherman who developed allergic symptoms when handling
codfish (35). Sensitization to allergens at the workplace occurs
usually via the skin or the respiratory tract. Resulting cutaneous
and respiratory diseases are a global health problem, with an
estimate that 25% of all asthma cases related to work (36).
The most common workplace allergens are relatively high-
molecular-weight proteins derived from cereal flour, natural
rubber latex, wood dust, livestock and laboratory animals,
seafood, industrial enzymes andmold (37). Animal and vegetable
high-molecular-weight proteins present in the aerosol and often
in aerosolized foods during food processing are themain inhalant
allergen sources. This type of IgE-mediated respiratory food
allergy usually does not generate any symptoms upon ingestion
of the source material and is suggested to reflect a new type of
allergy, termed Class 3 food allergy (37).
Over 400 occupational allergenic sources are identified
and documented as sensitizers, derived from plants, animals
and microbes. However, few have been characterized on the
molecular level and only a limited number of purified native or
recombinant allergens are available for testing (37). The current
WHO/IUIS database categorizes allergens by typical route of
exposure. However, in the case of occupational allergens the
specific route is often not clear, and the route of sensitization may
differ from the common route of elicitation and may be listed
as “unknown.”
A good example of the complex nature of identifying
“occupational allergens” among plants is wheat (Triticum
aestivum), where 28 allergens are registered with theWHO/IUIS,
however only 13 are confirmed food allergens. The route of
sensitization is categorized as “unknown” for 15, with 14 being
relevant in baker’s asthma and several allergens are relevant for
grass-pollen cross-reactivity, including profilin (Tri a 12) and
a subunit of the tetrameric heterologous a-amylase inhibitor
chloroform/methanol-soluble CM17 protein (Tri a 40).
Among animal derived allergens, tropomyosin is an abundant
and clear food allergen from crustacean shellfish and molluscs
that is also implicated in IgE binding and possibly in triggering
airway allergy from mites and some insects. In vitro IgE binding
studies and skin tests without clear clinical histories of the
patient can lead to uncertain diagnosis due to high amino acid
homology across diverse taxonomic groups. Clear differentiation
is often only possible if IgE inhibition studies are performed
and verification of biological activity. Dose and exposure are
important. The relevance of IgE binding to environmental
sources (house dust mite, cockroach and other organisms) often
leads to speculation about route of exposure in sensitization. Of
the 35 registered tropomyosins, 22 are known food allergens,
while 13 are not known to cause food allergies. Of these 10
are derived from insects or mites and the route of sensitization
is most likely via inhalation. Among the food allergens 19
tropomyosin are derived from different seafood species and are
relevant occupational allergens, however not identified as such
(38). Some animal allergens are not commonly recognized by
patients or clinicians due to limited exposure for most people to
the source. Hemoglobins from the insect “harlequin fly larvae,”
Chironomus thummii bind IgE from sera of those who raise the
insects for fish food (39). A few recent cases of occupational
allergy have been noted for workers who raise mealworms
(Tenebrio molitor) as a source of protein for processed human
food (9, 40). Some individuals have been newly sensitized at work,
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while for others it appears, they were sensitized by consumption
of shrimp or other crustaceans. Highly conserved tropomyosin
and a few enzymes such as arginine kinase may be responsible
for cross reactivity.
Many other foods have been reported in single case reports as
the cause of occupational allergies and asthma, and sensitization
by inhaled allergen exposure is therefore quite likely (41).
Importantly, though these proteins may be tolerated during
exposure by one route or by most people, they may not
be tolerated if exposure occurs differently and as such, the
WHO/IUIS nomenclature committee has not asked for in vivo
proof that new allergens illicit allergic responses to date, only
in vitro evidence and a good clinical history of symptoms.
SUMMARY AND CONCLUSIONS
Though molecular and scientific advances have led to improved
characterization of allergens and with-it increased clarity in
naming and categorizing them, the heterogeneous nature
of human data remains a challenge. This Sub-Committee
has in the past asked for minimal data characterizing
protein sequences, clinical symptoms of serum donors or
test subjects, IgE binding and allergic functionality. We see
great diversity in data submitted with candidate proteins. Our
recent publications are intended to help researchers focus on
relevant questions to improve the evidence that individual
proteins are allergens, and not simply cross-reactive in IgE
binding with only mild clinical consequences. Sequences
of the allergens and demonstration of IgE binding from
relevant symptomatic individuals are essential for defining
allergens. Some researchers would like to simply submit
to the Sub-Committee information about recombinant
proteins based only on genomic sequences of potential
allergen sources. While that activity may help predict
possible allergens, our goal is to call for direct proof of
allergenicity using subjects with clear clinical reactivity to source
materials, and with clear IgE binding to proteins presented at
representative concentrations.
The purpose of the allergen nomenclature system is to help
researchers, clinicians, pharmaceutical companies, regulators,
and the public clearly understand the identity of clinically
important allergens for diagnosis and to help ensure compliance
for improved safety.
However, our system is not perfect. Recent research shows
that some specific glycans are important allergens including α-gal
that is bound to tick and mammalian proteins and to glycol-
lipids. We do not define these structures as allergens but hope
to help publicize risks and educate consumers and allergists
about risks.
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